26 Mar 2021 by admin in UncategorizedComments Design Therapeutics Announces Pricing of Initial Public Offering
22 Mar 2021 by admin in UncategorizedComments Innoforce Pharmaceuticals Completes 625M CNY ($96M) Series A Financing
11 Mar 2021 by admin in UncategorizedComments Adicet Reports Fourth Quarter and Full Year 2020 Financial results
10 Mar 2021 by admin in UncategorizedComments Adicet Bio Announces Initiation of its First-in-Human Phase 1 Trial of ADI-001 for the Treatment of B
04 Mar 2021 by admin in UncategorizedComments Syros Reports Fourth Quarter and Full Year 2020 Financial Results
04 Mar 2021 by admin in UncategorizedComments NextCure Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial
03 Mar 2021 by admin in UncategorizedComments Tempest Therapeutics Announces Clinical Collaboration with Roche to Advance TPST-1120 into a Randomized Combination Study in First-line Hepatocellular Carcinoma
02 Mar 2021 by admin in UncategorizedComments Innoforce and dMed Collaborate to Accelerate the Development of Innovative Therapeutics
16 Feb 2021 by admin in UncategorizedComments Adicet Bio, Inc. Announces Closing of $152 Million Public Offering and Concurrent Private
10 Feb 2021 by admin in UncategorizedComments Adicet Bio, Inc. Announces Pricing of $135 Million Public Offering of Common Stock and Concurrent
09 Feb 2021 by admin in UncategorizedComments Adicet Bio, Inc. Announces Proposed Public Offering of Common Stock and Concurrent Private
02 Feb 2021 by admin in UncategorizedComments Kira Pharmaceuticals Announces First Participant Dosed in Phase 1 Clinical Trial for P014, a Bifunctional Biologic Medicine
27 Jan 2021 by admin in UncategorizedComments Citrine Medicine Announces Strategic Partnership to bring Alkindi® to China for Use in Pediatric Congenital Adrenal Hyperplasia (CAH)
26 Jan 2021 by admin in UncategorizedComments Arcellx Appoints Rami Elghandour as Chairman and Chief Executive Officer
14 Jan 2021 by admin in UncategorizedComments Dr. Han Myint Appointed as NextCure’s Chief Medical Officer
11 Jan 2021 by admin in UncategorizedComments Syros Announces Strategic Priorities and Expected Milestones
07 Jan 2021 by admin in UncategorizedComments KIRA PHARMACEUTICALS ANNOUNCES $53.5 MILLION SERIES B+ FINANCING TO ADVANCE LOGIC DRUG DISCOVERY PLATFORM AND PIPELINE OF COMPLEMENT-TARGETED THERAPIES
10 Dec 2020 by admin in UncategorizedComments Crescendo Biologics Expands its Ongoing Collaboration with Takeda
07 Dec 2020 by admin in UncategorizedComments Arcellx CART-ddBCMA Cell Therapy Demonstrates Deep and Durable Responses in the Treatment of Relapsed and Refractory Multiple Myeloma
01 Dec 2020 by admin in UncategorizedComments Adicet Announces Appointment of Dr. Bastiano Sanna to its Board of Directors
20 Nov 2020 by admin in UncategorizedComments Eluminex Biosciences, an Ophthalmology-Focused Biotechnology Company， Announces Closing of $50 Million Series A Financing
12 Nov 2020 by admin in UncategorizedComments Kira Pharmaceuticals Launches to Pioneer Novel Therapeutics for Complement-Mediated Diseases
06 Nov 2020 by admin in UncategorizedComments Thermo Fisher Scientific and Innoforce Partner to Establish Biologics and Steriles Drug Manufacturing Facility in China
05 Nov 2020 by admin in UncategorizedComments Syros Pharmaceuticals Reports Third Quarter 2020 Financial Results and Highlights Key Accomplishments and Upcoming Milestones
29 Oct 2020 by admin in UncategorizedComments Centrexion Therapeutics Raises $40.5 Million and Adds Lilly and Exome Asset Management as New Investors
29 Oct 2020 by admin in UncategorizedComments Citrine Medicine Advances Efforts to Create the Very First Rare Disease Ecosystem in China Through Strategic Partnership with Bioprojet to License Exclusive Rights for the Use of Orphan Narcolepsy Therapy Wakix® (pitolisant)
24 Oct 2020 by admin in UncategorizedComments Syros Presents Initial Data from Phase 1Clinical Trial of SY-5609
21 Oct 2020 by admin in UncategorizedComments SAM WHITING, M.D., PH.D., joins TEMPEST as executive vice president and chief medical officer
20 Oct 2020 by admin in UncategorizedComments Design Therapeutics Appoints Industry Veteran, Dr. João Siffert, as Chief Executive Officer
